Is my portfolio
One Report to Answer all your Questions!
Natco Pharma Ltd.
BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
916.25
-10.90 (-1.18%) Natco Pharma - Quaterly Results
Date: 11-11-2021
The sales for the September 2021 quarter moved down -31.01% to Rs. 3304.00 millions as compared to Rs. 4789.00 millions during the year ago period.The Company's Net profit for the September 2021 quarter have declined marginally to Rs. 536.00 millions as against Rs. 709.00 millions reported during the corresponding quarter ended.The company reported a degrowth in operating Profit to 897.00 millions from 1176.00 millions.
(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202109 | 202009 | % Var | 202109 | 202009 | % Var | 202103 | 202003 | % Var | |
| Sales | 3304.00 | 4789.00 | -31.01 | 7242.00 | 10111.00 | -28.38 | 16535.00 | 17902.00 | -7.64 |
| Other Income | 403.00 | 272.00 | 48.16 | 526.00 | 471.00 | 11.68 | 1011.00 | 1238.00 | -18.34 |
| PBIDT | 897.00 | 1176.00 | -23.72 | 2156.00 | 3101.00 | -30.47 | 5187.00 | 7018.00 | -26.09 |
| Interest | 32.00 | 27.00 | 18.52 | 50.00 | 60.00 | -16.67 | 113.00 | 206.00 | -45.15 |
| PBDT | 865.00 | 1149.00 | -24.72 | 2106.00 | 3041.00 | -30.75 | 5074.00 | 6812.00 | -25.51 |
| Depreciation | 342.00 | 284.00 | 20.42 | 673.00 | 560.00 | 20.18 | 1152.00 | 981.00 | 17.43 |
| PBT | 523.00 | 865.00 | -39.54 | 1433.00 | 2481.00 | -42.24 | 3922.00 | 5831.00 | -32.74 |
| TAX | -13.00 | 156.00 | -108.33 | 145.00 | 505.00 | -71.29 | 827.00 | 1086.00 | -23.85 |
| Deferred Tax | -113.00 | -50.00 | 126.00 | -110.00 | -115.00 | -4.35 | -106.00 | -205.00 | -48.29 |
| PAT | 536.00 | 709.00 | -24.40 | 1288.00 | 1976.00 | -34.82 | 3095.00 | 4745.00 | -34.77 |
| Equity | 365.00 | 364.00 | 0.27 | 365.00 | 364.00 | 0.27 | 365.00 | 364.00 | 0.27 |
| PBIDTM(%) | 27.15 | 24.56 | 10.56 | 29.77 | 30.67 | -2.93 | 31.37 | 39.20 | -19.98 |